6-KThe Wire
Alpha Tau Medical Ltd. files 6-K
Filed Apr 23, 2026 · 3mo ago · Accession 0001213900-26-046897
Plain English
Alpha Tau Medical Ltd. announced two significant clinical trial updates: the successful treatment of the first pancreatic cancer patient in Europe using Alpha DaRT® in the ACAPELLA trial, and FDA approval to expand the IMPACT trial to include pancreatic cancer patients receiving specific chemotherapy.
Filing details
- Company
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- CIK
- 1871321
- Form type
- 6-K
- Filing date
- Apr 23, 2026
- Report date
- Apr 23, 2026
- Document
- ea0287451-6k_alphatau.htm
- Size
- 50 KB